FcγRIIa is a target for modulation by TNFα in human neutrophils

Clinical Immunology

Volumn 117, Issue 1, 2005, Pages 78-86

  Belostocki, Kristina ^a   Park, Mee Soon ^a   Redecha, Patricia B ^a   Masuda, Emi ^a   Salmon, Jane E ^a   Pricop, Luminita ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Fc gamma receptors; Immune complexes; Inflammation; Infliximab; Interleukin 10; Neutrophils; Phagocytosis; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

FC RECEPTOR; INFLIXIMAB; INTERLEUKIN 10; MEPREDNISONE; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT; FC GAMMA RECEPTOR IIA; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LONGITUDINAL STUDY; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; UPREGULATION; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPRECIPITATION; PHAGOCYTOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; INTERLEUKIN-10; NEUTROPHILS; PHAGOCYTOSIS; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27244431775     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.07.001     Document Type: Article

References (47)

1. M.H. Pillinger, and S.B. Abramson The neutrophil in rheumatoid arthritis Rheum. Dis. Clin. North Am. 21 3 1995 691 714
2. B.T. Wipke, and P.M. Allen Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis J. Immunol. 167 3 2001 1601 1608
3. L. Harper, J.M. Williams, and C.O. Savage The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis Biochem. Soc. Trans. 32 Pt. 3 2004 502 506
4. C.J. Day, P. Hewins, and C.O. Savage New developments in the pathogenesis of ANCA-associated vasculitis Clin. Exp. Rheumatol. 21 6 Suppl. 32 2003 S35 S48
5. C.O. Savage The evolving pathogenesis of systemic vasculitis Clin. Med. 2 5 2002 458 464
6. A. Ben-Smith, S.K. Dove, A. Martin, M.J. Wakelam, and C.O. Savage Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation Blood 98 5 2001 1448 1455
7. H. Liu, R.M. Pope, Phagocytes: mechanisms of inflammation and tissue destruction. Rheum. Dis. Clin. North Am. 30 (1) (2004) 19-39, v.
8. G. Girardi, J. Berman, and P. Redecha Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome J. Clin. Invest. 112 11 2003 1644 1654
9. B.T. Wipke, Z. Wang, W. Nagengast, D.E. Reichert, and P.M. Allen Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes J. Immunol. 172 12 2004 7694 7702
10. F. Watson, L. Gasmi, and S.W. Edwards Stimulation of intracellular Ca2+ levels in human neutrophils by soluble immune complexes. Functional activation of FcgammaRIIIb during priming J. Biol. Chem. 272 29 1997 17944 17951
11. G. Fossati, R.C. Bucknall, and S.W. Edwards Insoluble and soluble immune complexes activate neutrophils by distinct activation mechanisms: changes in functional responses induced by priming with cytokines Ann. Rheum. Dis. 61 1 2002 13 19
12. F. Watson, and S.W. Edwards Stimulation of primed neutrophils by soluble immune complexes Biologicals 24 4 1996 307 311
13. 2+ elevations, activation of phospholipase D, and activation of the NADPH oxidase Biochem. Biophys. Res. Commun. 247 3 1998 819 826
14. H. Ji, K. Ohmura, and U. Mahmood Arthritis critically dependent on innate immune system players Immunity 16 2 2002 157 168
15. J.J. Robinson, F. Watson, M. Phelan, R.C. Bucknall, and S.W. Edwards Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis Ann. Rheum. Dis. 52 5 1993 347 353
16. H.L. Nurcombe, R.C. Bucknall, and S.W. Edwards Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo Ann. Rheum. Dis. 50 3 1991 147 153
17. J.D. Ji, I. Tassiulas, and K.H. Park-Min Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis J. Exp. Med. 197 11 2003 1573 1583
18. M.N. Sharif, I. Tassiulas, Y. Hu, I. Mecklenbrauker, A. Tarakhovsky, and L.B. Ivashkiv IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis J. Immunol. 172 10 2004 6476 6481
19. M. Kocher, M.E. Siegel, J.C. Edberg, and R.P. Kimberly Cross-linking of Fc gamma receptor IIa and Fc gamma receptor IIIb induces different proadhesive phenotypes on human neutrophils J. Immunol. 159 8 1997 3940 3948
20. G. Fossati, R.J. Moots, R.C. Bucknall, and S.W. Edwards Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes Arthritis Rheum. 46 5 2002 1351 1361
21. L. Pricop, P. Redecha, and J.L. Teillaud Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines J. Immunol. 166 1 2001 531 537
22. R.N. Stefanescu, M. Olferiev, Y. Liu, and L. Pricop Inhibitory Fc gamma receptors: from gene to disease J. Clin. Immunol. 24 4 2004 315 326
23. N. Barnes, A.L. Gavin, P.S. Tan, P. Mottram, F. Koentgen, and P.M. Hogarth FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses Immunity 16 3 2002 379 389
24. A. Ioan-Facsinay, S.J. de Kimpe, and S.M. Hellwig FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection Immunity 16 3 2002 391 402
25. P.L. van Lent, K. Nabbe, and A.B. Blom Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis Am. J. Pathol. 159 6 2001 2309 2320
26. S. Wijngaarden, J.G. van de Winkel, K.M. Jacobs, J.W. Bijlsma, F.P. Lafeber, and J.A. van Roon A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis Arthritis Rheum. 50 12 2004 3878 3887
27. Y.M.E. Liu, M.C. Blank, K. Kirou, X. Gao, M.S. Park, and L. Pricop Cytokine-mediated regulation of activating and inhibitory Fc gamma receptors in human monocytes J. Leukocyte Biol. 77 5 2005 767 776
28. F. Watson, J.J. Robinson, M. Phelan, R.C. Bucknall, and S.W. Edwards Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis Ann. Rheum. Dis. 52 5 1993 354 359
29. N.J. Goulding, S.M. Knight, J.L. Godolphin, and P.M. Guyre Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis Ann. Rheum. Dis. 51 4 1992 465 468
30. P.E. Lipsky, D.M. van der Heijde, and E.W. St. Clair Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N. Engl. J. Med. 343 22 2000 (Nov 30) 1594 1602
31. G. Harriman, L.K. Harper, and T.F. Schaible Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment Ann. Rheum. Dis. 58 Suppl. 1 1999 I61 I64
32. L. Cassard, M.A. Dragon-Durey, and A. Ralli Expression of low-affinity Fc gamma receptor by a human metastatic melanoma line Immunol. Lett. 75 1 2000 1 8
33. L. Pricop, J.E. Salmon, J.C. Edberg, and A.J. Beavis Flow cytometric quantitation of attachment and phagocytosis in phenotypically-defined subpopulations of cells using PKH26-labeled Fc gamma R-specific probes J. Immunol. Methods 205 1 1997 55 65
34. J.C. Edberg, and R.P. Kimberly Receptor specific probes for the study of Fc gamma receptor specific function J. Immunol. Methods 148 1-2 1992 179 187
35. L.L. Laichalk, J.M. Danforth, and T.J. Standiford Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity FEMS Immunol. Med. Microbiol. 15 4 1996 181 187
36. E. Roilides, H. Katsifa, S. Tsaparidou, T. Stergiopoulou, C. Panteliadis, and T.J. Walsh Interleukin 10 suppresses phagocytic and antihyphal activities of human neutrophils Cytokine 12 4 2000 379 387
37. J.E. Salmon, S.S. Millard, N.L. Brogle, and R.P. Kimberly Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner J. Clin. Invest. 95 6 1995 2877 2885
38. J.C. Edberg, J.E. Salmon, and R.P. Kimberly Functional capacity of Fc gamma receptor III (CD16) on human neutrophils Immunol. Res. 11 3-4 1992 239 251
39. J.E. Salmon, N.L. Brogle, J.C. Edberg, and R.P. Kimberly Fc gamma receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fc gamma receptor II J. Immunol. 146 3 1991 997 1004
40. L. Pricop, J. Gokhale, P. Redecha, S.C. Ng, and J.E. Salmon Reactive oxygen intermediates enhance Fc gamma receptor signaling and amplify phagocytic capacity J. Immunol. 162 12 1999 7041 7048
41. J.J. Robinson, F. Watson, R.C. Bucknall, and S.W. Edwards Role of Fc gamma receptors in the activation of neutrophils by soluble and insoluble immunoglobulin aggregates isolated from the synovial fluid of patients with rheumatoid arthritis Ann. Rheum. Dis. 53 8 1994 515 520
42. R.W. Hostoffer, I. Krukovets, and M. Berger Enhancement by tumor necrosis factor-alpha of Fc alpha receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes J. Infect. Dis. 170 1 1994 82 87
43. C. Tascini, F. Baldelli, and C. Monari Inhibition of fungicidal activity of polymorphonuclear leukocytes from HIV-infected patients by interleukin (IL)-4 and IL-10 AIDS 10 5 1996 477 483
44. F. Capsoni, F. Minonzio, A.M. Ongari, V. Carbonelli, A. Galli, and C. Zanussi Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils Scand. J. Immunol. 45 3 1997 269 275
45. C. Bogdan, J. Paik, Y. Vodovotz, and C. Nathan Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10 J. Biol. Chem. 267 32 1992 23301 23308
46. C. Bogdan, and C. Nathan Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10 Ann. N. Y. Acad. Sci. 685 1993 713 739
47. L.A. Bober, A. Rojas-Triana, and J.V. Jackson Regulatory effects of interleukin-4 and interleukin-10 on human neutrophil function ex vivo and on neutrophil influx in a rat model of arthritis Arthritis Rheum. 43 12 2000 2660 2667